OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer -

Clinical trial NCT03750175 · COMPLETED

Trial details

NCT number: NCT03750175
Sponsor: Karen-Lise Garm Spindler
Status: COMPLETED
Study type: OBSERVATIONAL

Colorectal Cancer Metastatic Circulating Tumor DNA KRAS Gene Mutation NRAS Gene Mutation BRAF Gene Mutation Epidermal Growth Factor Receptor Inhibitor

Start date: 2018-06-01
Primary completion: 2022-06-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.